Biogen Idec Inc. &Verint Systems Inc. Announcements: (NASDAQ: BIIB), (NASDAQ: VRNT)
Biogen Idec Inc. (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA™ (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS). Biogen Idec will make this oral capsule available to people living with MS in the United States in the coming days.
View full press release